ANVS vs MMC · $80.4M cap vs P/E 22, rev $24.46B
Annovis Bio Inc (ANVS) versus Marsh & McLennan Companies Inc (MMC) — a side-by-side from cached financials, not a winner call.
Annovis Bio Inc (ANVS) is a biotechnology company listed on US.
Marsh & McLennan Companies Inc (MMC) is a insurance brokers company listed on US.
Latest reported ANVS revenue for 2026-06-30 was $0. Net income was -$32.4M. ANVS currently screens at market cap $80.4M.
Latest reported MMC revenue for 2024-12-31 was $24.46B. Net income was $4.12B. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
ANVS currently screens at market cap $80.4M. MMC currently screens at market cap $89.82B and trailing P/E 21.9.
Not investment advice. Open the ANVS and MMC stock pages for the full models.
Not investment advice.